Logo image of BX

BLACKSTONE INC (BX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BX - US09260D1072 - Common Stock

155.57 USD
+0.41 (+0.26%)
Last: 12/24/2025, 8:16:40 PM
155.57 USD
0 (0%)
After Hours: 12/24/2025, 8:16:40 PM
Fundamental Rating

5

Overall BX gets a fundamental rating of 5 out of 10. We evaluated BX against 238 industry peers in the Capital Markets industry. While BX belongs to the best of the industry regarding profitability, there are concerns on its financial health. BX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BX had positive earnings in the past year.
BX had a positive operating cash flow in the past year.
In the past 5 years BX has always been profitable.
BX had a positive operating cash flow in each of the past 5 years.
BX Yearly Net Income VS EBIT VS OCF VS FCFBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

BX has a Return On Assets of 5.82%. This is in the better half of the industry: BX outperforms 73.95% of its industry peers.
Looking at the Return On Equity, with a value of 32.27%, BX belongs to the top of the industry, outperforming 97.06% of the companies in the same industry.
The Return On Invested Capital of BX (16.48%) is better than 92.02% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BX is significantly above the industry average of 7.00%.
The last Return On Invested Capital (16.48%) for BX is above the 3 year average (12.81%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.82%
ROE 32.27%
ROIC 16.48%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
BX Yearly ROA, ROE, ROICBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

Looking at the Profit Margin, with a value of 20.56%, BX is in line with its industry, outperforming 55.88% of the companies in the same industry.
In the last couple of years the Profit Margin of BX has declined.
Looking at the Operating Margin, with a value of 50.03%, BX belongs to the top of the industry, outperforming 88.66% of the companies in the same industry.
In the last couple of years the Operating Margin of BX has remained more or less at the same level.
Industry RankSector Rank
OM 50.03%
PM (TTM) 20.56%
GM N/A
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
BX Yearly Profit, Operating, Gross MarginsBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The number of shares outstanding for BX has been increased compared to 1 year ago.
Compared to 5 years ago, BX has more shares outstanding
BX has a better debt/assets ratio than last year.
BX Yearly Shares OutstandingBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BX Yearly Total Debt VS Total AssetsBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

BX has an Altman-Z score of 3.64. This indicates that BX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.64, BX is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
The Debt to FCF ratio of BX is 3.29, which is a good value as it means it would take BX, 3.29 years of fcf income to pay off all of its debts.
BX has a Debt to FCF ratio of 3.29. This is in the better half of the industry: BX outperforms 76.89% of its industry peers.
A Debt/Equity ratio of 1.43 is on the high side and indicates that BX has dependencies on debt financing.
BX has a Debt to Equity ratio of 1.43. This is in the lower half of the industry: BX underperforms 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 3.29
Altman-Z 3.64
ROIC/WACCN/A
WACCN/A
BX Yearly LT Debt VS Equity VS FCFBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

BX has a Current Ratio of 0.71. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
BX's Current ratio of 0.71 is on the low side compared to the rest of the industry. BX is outperformed by 66.39% of its industry peers.
A Quick Ratio of 0.71 indicates that BX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.71, BX is doing worse than 65.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.71
BX Yearly Current Assets VS Current LiabilitesBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

7

3. Growth

3.1 Past

BX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.71%, which is quite impressive.
The Earnings Per Share has been growing by 14.97% on average over the past years. This is quite good.
Looking at the last year, BX shows a quite strong growth in Revenue. The Revenue has grown by 15.22% in the last year.
The Revenue has been growing by 12.51% on average over the past years. This is quite good.
EPS 1Y (TTM)35.71%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%50.5%
Revenue 1Y (TTM)15.22%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%35.68%

3.2 Future

Based on estimates for the next years, BX will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.29% on average per year.
Based on estimates for the next years, BX will show a quite strong growth in Revenue. The Revenue will grow by 15.92% on average per year.
EPS Next Y18.57%
EPS Next 2Y19.53%
EPS Next 3Y20.6%
EPS Next 5Y17.29%
Revenue Next Year12.2%
Revenue Next 2Y18.39%
Revenue Next 3Y19.22%
Revenue Next 5Y15.92%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BX Yearly Revenue VS EstimatesBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BX Yearly EPS VS EstimatesBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.23 indicates a quite expensive valuation of BX.
BX's Price/Earnings ratio is a bit more expensive when compared to the industry. BX is more expensive than 68.91% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.59, BX is valued at the same level.
The Price/Forward Earnings ratio is 23.47, which indicates a rather expensive current valuation of BX.
61.76% of the companies in the same industry are cheaper than BX, based on the Price/Forward Earnings ratio.
BX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.23
Fwd PE 23.47
BX Price Earnings VS Forward Price EarningsBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BX is valued a bit cheaper than 65.55% of the companies in the same industry.
BX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 51.97
EV/EBITDA 30.02
BX Per share dataBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

BX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of BX may justify a higher PE ratio.
BX's earnings are expected to grow with 20.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.52
PEG (5Y)1.89
EPS Next 2Y19.53%
EPS Next 3Y20.6%

5

5. Dividend

5.1 Amount

BX has a Yearly Dividend Yield of 3.05%.
Compared to an average industry Dividend Yield of 6.43, BX has a dividend in line with its industry peers.
BX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 3.05%

5.2 History

On average, the dividend of BX grows each year by 11.16%, which is quite nice.
BX has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BX decreased recently.
Dividend Growth(5Y)11.16%
Div Incr Years1
Div Non Decr Years1
BX Yearly Dividends per shareBX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

BX pays out 203.27% of its income as dividend. This is not a sustainable payout ratio.
The dividend of BX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP203.27%
EPS Next 2Y19.53%
EPS Next 3Y20.6%
BX Yearly Income VS Free CF VS DividendBX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BX Dividend Payout.BX Dividend Payout, showing the Payout Ratio.BX Dividend Payout.PayoutRetained Earnings

BLACKSTONE INC

NYSE:BX (12/24/2025, 8:16:40 PM)

After market: 155.57 0 (0%)

155.57

+0.41 (+0.26%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-23 2025-10-23/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners71.12%
Inst Owner Change-12.35%
Ins Owners0.79%
Ins Owner Change-3.22%
Market Cap189.77B
Revenue(TTM)13.17B
Net Income(TTM)2.71B
Analysts77.5
Price Target182.98 (17.62%)
Short Float %1.45%
Short Ratio2.46
Dividend
Industry RankSector Rank
Dividend Yield 3.05%
Yearly Dividend6.1
Dividend Growth(5Y)11.16%
DP203.27%
Div Incr Years1
Div Non Decr Years1
Ex-Date11-03 2025-11-03 (1.29)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.67%
Min EPS beat(2)7.03%
Max EPS beat(2)20.3%
EPS beat(4)4
Avg EPS beat(4)10.11%
Min EPS beat(4)0.65%
Max EPS beat(4)20.3%
EPS beat(8)6
Avg EPS beat(8)6.71%
EPS beat(12)7
Avg EPS beat(12)4.19%
EPS beat(16)11
Avg EPS beat(16)7.34%
Revenue beat(2)2
Avg Revenue beat(2)4.85%
Min Revenue beat(2)2.72%
Max Revenue beat(2)6.98%
Revenue beat(4)3
Avg Revenue beat(4)3.58%
Min Revenue beat(4)-0.22%
Max Revenue beat(4)6.98%
Revenue beat(8)3
Avg Revenue beat(8)0.14%
Revenue beat(12)3
Avg Revenue beat(12)-8.54%
Revenue beat(16)5
Avg Revenue beat(16)-3.33%
PT rev (1m)0.59%
PT rev (3m)-1.86%
EPS NQ rev (1m)-0.54%
EPS NQ rev (3m)0.21%
EPS NY rev (1m)-0.2%
EPS NY rev (3m)5.83%
Revenue NQ rev (1m)-1.09%
Revenue NQ rev (3m)0.98%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)2.68%
Valuation
Industry RankSector Rank
PE 28.23
Fwd PE 23.47
P/S 14.41
P/FCF 51.97
P/OCF 50.51
P/B 22.61
P/tB 29.83
EV/EBITDA 30.02
EPS(TTM)5.51
EY3.54%
EPS(NY)6.63
Fwd EY4.26%
FCF(TTM)2.99
FCFY1.92%
OCF(TTM)3.08
OCFY1.98%
SpS10.8
BVpS6.88
TBVpS5.22
PEG (NY)1.52
PEG (5Y)1.89
Graham Number29.21
Profitability
Industry RankSector Rank
ROA 5.82%
ROE 32.27%
ROCE 19.75%
ROIC 16.48%
ROICexc 18%
ROICexgc 19.41%
OM 50.03%
PM (TTM) 20.56%
GM N/A
FCFM 27.72%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
ROICexc(3y)14.24%
ROICexc(5y)19.2%
ROICexgc(3y)15.53%
ROICexgc(5y)21.12%
ROCE(3y)15.37%
ROCE(5y)21.01%
ROICexgc growth 3Y-21.19%
ROICexgc growth 5Y9.44%
ROICexc growth 3Y-21.05%
ROICexc growth 5Y9.86%
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 3.29
Debt/EBITDA 1.81
Cap/Depr 292.78%
Cap/Sales 0.8%
Interest Coverage 13.52
Cash Conversion 56.69%
Profit Quality 134.85%
Current Ratio 0.71
Quick Ratio 0.71
Altman-Z 3.64
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)360.42%
Cap/Depr(5y)264.86%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.63%
Profit Quality(3y)249.28%
Profit Quality(5y)197.86%
High Growth Momentum
Growth
EPS 1Y (TTM)35.71%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%50.5%
EPS Next Y18.57%
EPS Next 2Y19.53%
EPS Next 3Y20.6%
EPS Next 5Y17.29%
Revenue 1Y (TTM)15.22%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%35.68%
Revenue Next Year12.2%
Revenue Next 2Y18.39%
Revenue Next 3Y19.22%
Revenue Next 5Y15.92%
EBIT growth 1Y17.51%
EBIT growth 3Y-19.82%
EBIT growth 5Y13.91%
EBIT Next Year6.36%
EBIT Next 3Y16.49%
EBIT Next 5Y12.15%
FCF growth 1Y0.46%
FCF growth 3Y-4.46%
FCF growth 5Y12.44%
OCF growth 1Y-3.09%
OCF growth 3Y-4.41%
OCF growth 5Y12.14%

BLACKSTONE INC / BX FAQ

Can you provide the ChartMill fundamental rating for BLACKSTONE INC?

ChartMill assigns a fundamental rating of 5 / 10 to BX.


Can you provide the valuation status for BLACKSTONE INC?

ChartMill assigns a valuation rating of 3 / 10 to BLACKSTONE INC (BX). This can be considered as Overvalued.


How profitable is BLACKSTONE INC (BX) stock?

BLACKSTONE INC (BX) has a profitability rating of 7 / 10.


What is the valuation of BLACKSTONE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BLACKSTONE INC (BX) is 28.23 and the Price/Book (PB) ratio is 22.61.


How financially healthy is BLACKSTONE INC?

The financial health rating of BLACKSTONE INC (BX) is 3 / 10.